poorlytamiflu | Poniard Pharmaceuticals Announces Picoplatin …
candidate, at the 2008 Gastrointestinal Cancers Symposium, a encounter of the. American Society of Clinical Oncology (ASCO) which is being held in. Orlando, Fla. The poster awarding included safety evidence from a Phase 1 study of … a blue ribbon-assemble treatment fitted metastatic colorectal cancer (mCRC). The Inject 1 about seeks to prove the peak tolerated dose of picoplatin and contribute info on the safety of picoplatin when combined with 5FU and …
See original here:
poorlytamiflu | Poniard Pharmaceuticals Announces Picoplatin …
Stumble Upon
Del.icio.us
Buzz
